EU Novel Food Compliance for Probiotic Gummies: What Non-EU Manufacturers Must Know
A Dutch supplement brand contracted an Indian manufacturer to produce a probiotic gummy for the European market. The formulation was sound, the stability data was strong, and the first shipment cleared customs. Six months later, a competitor filed a challenge - the probiotic strain used in the product hadn't been authorised under the EU Novel Food Regulation. The product was pulled from sale in three countries. The brand lost a quarter's revenue and a retail partnership that had taken two years to build.
EU novel food compliance for probiotic gummies is one of the most misunderstood regulatory barriers in the global supplement industry. Many manufacturers outside Europe - particularly in India, the US, and parts of Asia - don't fully grasp that a probiotic strain sold freely in their domestic market may be classified as a "novel food" in the EU and require formal authorisation before it can be legally marketed.
If you're manufacturing probiotic gummies for European markets, this is the regulatory framework you need to understand before you commit to a formulation.
What Is the EU Novel Food Regulation?
The EU Novel Food Regulation (Regulation (EU) 2015/2283) governs the approval and marketing of foods and food ingredients that were not consumed to a significant degree within the EU before May 1997.
The logic is straightforward: if European consumers didn't have meaningful exposure to a food or ingredient before 1997, it's considered "novel" and requires a safety assessment before it can be sold.
For probiotic gummies, this regulation matters because:
- Many probiotic strains - particularly those developed or commercialised after 1997 - may be classified as novel foods in the EU
- Specific strain-level classification applies: a species-level history of use doesn't automatically authorise every strain within that species
- The gummy format itself doesn't trigger novel food classification, but the ingredients inside it might
The regulation applies uniformly across all 27 EU member states and, with some post-Brexit modifications, informs UK regulatory thinking as well.
Which Probiotic Strains Are Affected?
This is where the detail matters. The EU Novel Food Catalogue - maintained by the European Commission - provides guidance on which organisms and ingredients are considered novel.
Generally not novel (significant history of consumption pre-1997)
Several well-established probiotic species have documented histories of consumption in the EU through fermented foods, dairy products, and traditional preparations:
- Lactobacillus acidophilus
- Lactobacillus rhamnosus
- Lactobacillus casei
- Bifidobacterium lactis
- Bifidobacterium longum
- Streptococcus thermophilus
However, the novel food assessment can apply at the strain level, not just the species level. A new, proprietary strain of Lactobacillus rhamnosus developed for specific functional claims may require novel food assessment even though the species itself has history of use.
Commonly flagged as novel
- Bacillus coagulans - this is the strain most frequently used in gummy manufacturing due to its heat tolerance. However, certain strains of Bacillus coagulans have been assessed under novel food regulations and require specific authorisation.
- Heat-killed (tyndallised) probiotics - these are a growing category, but their novel food status depends on whether the specific killed preparation has a history of use
- Engineered or modified strains - any genetically modified probiotic strain requires both novel food authorisation and GMO approval
The catalogue is not exhaustive
The EU Novel Food Catalogue is a guidance tool, not a definitive legal list. If your strain isn't listed, that doesn't mean it's approved - it means you may need to conduct your own assessment of its history of consumption in the EU.
Learn about Probiotic Gummies Manufacturing
The Novel Food Authorisation Process
If your probiotic strain requires novel food authorisation, here's what the process involves:
Step 1: Determine if authorisation is needed
Check the EU Novel Food Catalogue and consult with a regulatory specialist. If the strain (at the specific strain level, not just species) doesn't have a documented history of significant consumption in the EU before 1997, authorisation is likely required.
Step 2: Prepare the application dossier
The dossier is submitted to the European Commission and assessed by the European Food Safety Authority (EFSA). It must include:
- Identity and characterisation of the probiotic organism (genus, species, strain designation, genome data if available)
- Production process - how the organism is cultivated, harvested, and processed
- Compositional data - full analytical characterisation of the probiotic ingredient
- History of use - any documented consumption outside the EU, traditional use evidence
- Safety data - toxicological studies, in vitro and in vivo safety assessments, clinical data if available
- Proposed conditions of use - target population, dose, format (in this case, gummies), and intended markets
Step 3: EFSA assessment
EFSA evaluates the dossier and may request additional data. The assessment typically takes 9–18 months from dossier acceptance to opinion publication. This timeline can extend if EFSA requests supplementary studies.
Step 4: Commission authorisation
Following a favourable EFSA opinion, the European Commission issues an implementing regulation authorising the novel food. The authorisation specifies permitted conditions of use (maximum dose, target foods, labelling requirements).
Step 5: Union List entry
Authorised novel foods are added to the Union List (Regulation (EU) 2017/2470), which is the definitive register of authorised novel food ingredients in the EU.
Timeline reality
From initial dossier preparation to authorisation, the full process can take 2–4 years. This is not a quick regulatory fix - it's a strategic investment that needs to be factored into product development timelines years before launch.
The Traditional Food Notification Alternative
For probiotic ingredients with a documented history of safe use outside the EU - for example, strains used traditionally in Indian, Japanese, or Korean fermented foods - a simplified pathway exists.
The Traditional Food from Third Countries notification (under Article 14 of the Novel Food Regulation) allows ingredients with at least 25 years of documented safe use as a food in a non-EU country to be notified rather than going through the full authorisation process.
Requirements
- Evidence of 25+ years of safe consumption in a non-EU country
- Compositional data
- No safety concerns raised during the EU assessment period
- Notification submitted to the European Commission with supporting documentation
Assessment timeline
Member states and EFSA have 4 months from notification to raise safety objections. If no substantiated objections are raised, the ingredient is authorised for the EU market.
This pathway is faster and less expensive than the full novel food application, but it requires genuine traditional use evidence - not just a history of commercial sale. A probiotic strain developed through modern biotechnology is unlikely to qualify, regardless of how long the parent species has been consumed.
What This Means for Non-EU Manufacturers
For Indian manufacturers producing probiotic gummies for EU-bound brands, the novel food regulation creates specific obligations:
Formulation responsibility
The manufacturer must confirm that every probiotic strain in the formulation is either:
- Not classified as novel in the EU (documented species-level history of use, with no strain-level concerns), or
- Authorised under the Novel Food Regulation and listed in the Union List, or
- Subject to a pending application with a clear timeline to authorisation
Using a strain that hasn't been verified against the Novel Food Catalogue is a compliance risk that will eventually surface - either through regulatory enforcement, competitor challenges, or importer due diligence.
Documentation for EU importers
EU importers are responsible for ensuring that products placed on the EU market comply with all applicable regulations, including novel food. Your manufacturer should be able to provide:
- Strain identification documentation (genus, species, strain designation)
- Novel food status confirmation (with reference to the EU catalogue or authorisation regulation)
- Certificate of Analysis confirming the strain identity for each batch
- Any relevant EFSA opinions or authorisation references
Export dossier inclusion
For an EU-compliant probiotic gummy CMO, novel food compliance documentation should be a standard part of the export dossier - not something the brand has to chase separately.
Explore Export-Ready Manufacturing
Country-Specific Nuances Within the EU
While the Novel Food Regulation applies uniformly across the EU, enforcement and market expectations vary by country:
Netherlands
The Netherlands Food and Consumer Product Safety Authority (NVWA) is relatively active in monitoring novel food compliance for supplements. Dutch market entry requires careful regulatory preparation.
Germany
The Federal Office of Consumer Protection and Food Safety (BVL) maintains its own guidance on novel food status and is known for rigorous enforcement. Germany is the largest supplement market in Europe - and one of the hardest to enter without proper compliance.
France
DGCCRF (the French consumer protection authority) enforces novel food compliance and has its own mutual recognition procedures for certain ingredients. French labelling requirements are also specific.
Italy
A significant supplement market with generally favourable regulatory attitudes toward probiotics, but still bound by the Novel Food Regulation for strain-level authorisation.
Brands targeting multiple EU countries should work with a regulatory consultant who understands country-specific enforcement patterns - and with a manufacturer whose export dossier covers all relevant documentation.
Post-Brexit UK: A Parallel Framework
Since Brexit, the UK operates its own novel food framework, managed by the Food Standards Agency (FSA). The principles are similar to the EU system, but the authorisation process is separate.
Key differences:
- The UK maintains its own Novel Food Catalogue and approved list
- Applications are submitted to the FSA, not the European Commission
- EFSA opinions issued before Brexit may be recognised, but new applications require FSA assessment
- Timeline and process requirements are broadly comparable
For brands selling into both the EU and UK, this means two separate regulatory assessments may be required for the same probiotic strain. Plan for this in your product development timeline.
FAQ
Do all probiotic strains require novel food authorisation in the EU? No. Many well-established species (such as Lactobacillus acidophilus, Bifidobacterium lactis) have documented histories of consumption in the EU and are generally not considered novel at the species level. However, strain-level assessment may apply to newer, proprietary strains. Always verify against the EU Novel Food Catalogue.
How long does novel food authorisation take? The full process - from dossier preparation to Commission authorisation - typically takes 2–4 years. The Traditional Food notification pathway is faster (approximately 4–6 months from notification), but only applies to ingredients with 25+ years of documented safe use in a non-EU country.
Can I sell a probiotic gummy in the EU while the novel food application is pending? Generally, no. Products containing novel food ingredients that haven't been authorised cannot be legally placed on the EU market, even if an application is in progress. There are limited exceptions for ingredients already on the market before January 2018, but these are case-specific.
Is the manufacturer or the brand responsible for novel food compliance? Legally, the entity placing the product on the EU market (typically the importer or brand) bears primary responsibility. However, the manufacturer is responsible for providing accurate strain identification, documentation, and novel food status information. A competent EU-compliant probiotic gummy manufacturer will proactively address novel food compliance as part of the formulation process.
Does novel food status affect probiotic health claims in the EU? Novel food authorisation and health claims are separate regulatory processes. Even if a probiotic strain is authorised as a novel food, making specific health claims (e.g., "supports digestive health") requires additional authorisation under the EU Health Claims Regulation (EC No 1924/2006). As of 2026, the European Commission has not authorised any specific health claims for probiotics - which means claim language must be very carefully managed.
Targeting the EU Market with Probiotic Gummies?
If you're developing a probiotic gummy line for European markets and need a manufacturer who understands the novel food landscape, provides strain-level documentation, and builds compliance into the formulation process - share your brief and target market details with our team.
We work with brands entering the Netherlands, Germany, UK, and wider EU markets, with formulation and documentation support designed for the regulatory requirements these markets demand.
Explore Export-Ready Manufacturing Request a Project Brief
Want to discuss your formulation?
Our experts help brands launch technically complex probiotic and functional gummies.
